ChenGuang Biotech Group Co., Ltd.

Equities

300138

CNE100000WC5

Food Processing

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
9.16 CNY -1.51% Intraday chart for ChenGuang Biotech Group Co., Ltd. -6.05% -31.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023. CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. CI
Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023. CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. CI
ChenGuang Biotech Group Co., Ltd. commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on November 17, 2023. CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
US targets two China-based firms over forced labor practices -DHS RE
Chenguang Biotech Group Co., Ltd. Announces Management Appointment CI
ChenGuang Biotech Group Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 17 May 2023 CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
ChenGuang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2022 CI
ChenGuang Biotech Group Co., Ltd. Proposes Final Cash Dividend for the Year 2022 CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chenguang Biotech Sees 28% Rise in FY'22 Profit MT
Wang Guangming signed the share transfer agreement to acquire 4.27% stake in Qingdao Spicy Workshop Food Co., Ltd. for 12.40 million. CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Liu Yingshan signed Equity Transfer Agreement to acquire Xinjiang Tianjiao Hongan Agricultural Technology Co., Ltd. from ChenGuang Biotech Group Co., Ltd. and Xinjiang Chenxi Pepper Industry Co., Ltd. for CNY 88.3 million. CI
Chenguang Biotech Group Co., Ltd. Announces 2021 Final Cash Dividend Proposal on A Shares, Payable on 1 June 2022 CI
UBS Adjusts ChenGuang Biotech’s Price Target to 21.50 Yuan From 20.80 Yuan, Keeps at Buy MT
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chenguang Biotech Group Co., Ltd. Approves Cash Dividend CI
UBS Adjusts Chenguang Biotech Group's Price Target to 20.8 Yuan From 19, Keeps at Buy MT
Chart ChenGuang Biotech Group Co., Ltd.
More charts
Chenguang Biotech Group Co., Ltd. is a China-based company principally engaged in the manufacture and sales of natural pigment extracts, natural spices extracts, essential oil extracts, natural supplement and medicine extracts, fat and protein and others. The Company’s products include pigment, spices, supplement and medicine products, cottonseed products and others. The Company distributes its products in domestic and to overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
9.16 CNY
Average target price
17.66 CNY
Spread / Average Target
+92.77%
Consensus
  1. Stock Market
  2. Equities
  3. 300138 Stock
  4. News ChenGuang Biotech Group Co., Ltd.
  5. UBS Adjusts Chenguang Biotech Group's Price Target to 20.8 Yuan From 19, Keeps at Buy